{"id":"https://openalex.org/W1506037014","doi":"https://doi.org/10.18632/oncotarget.1955","title":"ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer","display_name":"ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer","publication_year":2014,"publication_date":"2014-05-08","ids":{"openalex":"https://openalex.org/W1506037014","doi":"https://doi.org/10.18632/oncotarget.1955","mag":"1506037014","pmid":"https://pubmed.ncbi.nlm.nih.gov/24952873","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4196152"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.1955","doi":"https://doi.org/10.18632/oncotarget.1955","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.1955","pdf_url":"https://www.oncotarget.com/article/1955/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.oncotarget.com/article/1955/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108354671","display_name":"Katharina Feldinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Katharina Feldinger","raw_affiliation_strings":["Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]},{"raw_affiliation_string":"Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020078965","display_name":"Daniele Generali","orcid":"https://orcid.org/0000-0003-2480-3855","observed_orcids":["https://orcid.org/0000-0003-2480-3855"]},"institutions":[{"id":"https://openalex.org/I4210165579","display_name":"Istituti Ospitalieri di Cremona","ror":"https://ror.org/05w07vs91","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165579"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniele Generali","raw_affiliation_strings":["U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Cremona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Cremona, Italy","institution_ids":["https://openalex.org/I4210165579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006116515","display_name":"Gabriela Kr\u00e4mer-Marek","orcid":"https://orcid.org/0000-0002-8053-3880","observed_orcids":["https://orcid.org/0000-0002-8053-3880"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Gabriela Kramer-Marek","raw_affiliation_strings":["Institute of Cancer Research, Division of Radiotherapy and Imaging, Belmont, Sutton, Surrey, UK (New address)","National Institutes of Health, Radiation Oncology Branch, Bethesda MD, US","National Institutes of Health, Radiation Oncology Branch, Bethesda MD, US. Institute of Cancer Research, Division of Radiotherapy and Imaging, Belmont, Sutton, Surrey, UK (New address)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Division of Radiotherapy and Imaging, Belmont, Sutton, Surrey, UK (New address)","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"National Institutes of Health, Radiation Oncology Branch, Bethesda MD, US","institution_ids":["https://openalex.org/I1299303238"]},{"raw_affiliation_string":"National Institutes of Health, Radiation Oncology Branch, Bethesda MD, US. Institute of Cancer Research, Division of Radiotherapy and Imaging, Belmont, Sutton, Surrey, UK (New address)","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036009351","display_name":"Merel Gijsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Merel Gijsen","raw_affiliation_strings":["Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]},{"raw_affiliation_string":"Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035780833","display_name":"Tzi Bun Ng","orcid":"https://orcid.org/0000-0001-7951-8838","observed_orcids":["https://orcid.org/0000-0001-7951-8838"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Tzi Bun Ng","raw_affiliation_strings":["School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Tai Po Road, Sha Tin, Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Tai Po Road, Sha Tin, Hong Kong","institution_ids":["https://openalex.org/I177725633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062088469","display_name":"Jack Ho Wong","orcid":"https://orcid.org/0000-0002-9732-986X","observed_orcids":["https://orcid.org/0000-0002-9732-986X"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Jack Ho Wong","raw_affiliation_strings":["School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Tai Po Road, Sha Tin, Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Tai Po Road, Sha Tin, Hong Kong","institution_ids":["https://openalex.org/I177725633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071939535","display_name":"Carla Strina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165579","display_name":"Istituti Ospitalieri di Cremona","ror":"https://ror.org/05w07vs91","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165579"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carla Strina","raw_affiliation_strings":["U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Cremona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Cremona, Italy","institution_ids":["https://openalex.org/I4210165579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113551023","display_name":"Mariarosa Cappelletti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165579","display_name":"Istituti Ospitalieri di Cremona","ror":"https://ror.org/05w07vs91","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165579"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mariarosa Cappelletti","raw_affiliation_strings":["U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Cremona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Cremona, Italy","institution_ids":["https://openalex.org/I4210165579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024279311","display_name":"Daniele Andreis","orcid":"https://orcid.org/0000-0001-6686-5662","observed_orcids":["https://orcid.org/0000-0001-6686-5662"]},"institutions":[{"id":"https://openalex.org/I4210165579","display_name":"Istituti Ospitalieri di Cremona","ror":"https://ror.org/05w07vs91","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165579"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniele Andreis","raw_affiliation_strings":["U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Cremona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Instituti Ospitalieri di Cremona, Cremona, Italy","institution_ids":["https://openalex.org/I4210165579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101694082","display_name":"Jiliang Li","orcid":"https://orcid.org/0000-0001-6200-1007","observed_orcids":["https://orcid.org/0000-0001-6200-1007"]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ji-Liang Li","raw_affiliation_strings":["Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023518824","display_name":"Esther Bridges","orcid":"https://orcid.org/0000-0002-6958-6279","observed_orcids":["https://orcid.org/0000-0002-6958-6279"]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Esther Bridges","raw_affiliation_strings":["Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033223978","display_name":"Helen Turley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Helen Turley","raw_affiliation_strings":["Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058291433","display_name":"Russell Leek","orcid":"https://orcid.org/0000-0002-8038-8660","observed_orcids":["https://orcid.org/0000-0002-8038-8660"]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Russell Leek","raw_affiliation_strings":["Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038968301","display_name":"Ioannis Roxanis","orcid":"https://orcid.org/0000-0002-9920-514X","observed_orcids":["https://orcid.org/0000-0002-9920-514X"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210147381","display_name":"Oxford University Hospitals NHS Trust","ror":"https://ror.org/03h2bh287","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ioannis Roxanis","raw_affiliation_strings":["Department of Cellular Pathology, Oxford University Hospitals and Oxford Biomedical Research Centre, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular Pathology, Oxford University Hospitals and Oxford Biomedical Research Centre, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210147381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041336753","display_name":"Jacek Capala","orcid":"https://orcid.org/0000-0001-7631-0310","observed_orcids":["https://orcid.org/0000-0001-7631-0310"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacek Capala","raw_affiliation_strings":["National Institutes of Health, Radiation Oncology Branch, Bethesda MD, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health, Radiation Oncology Branch, Bethesda MD, US","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016235541","display_name":"Gillian Murphy","orcid":"https://orcid.org/0000-0003-0287-1910","observed_orcids":["https://orcid.org/0000-0003-0287-1910"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gillian Murphy","raw_affiliation_strings":["Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, UK","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079633934","display_name":"Adrian Llewellyn Harris","orcid":"https://orcid.org/0000-0003-1376-8409","observed_orcids":["https://orcid.org/0000-0003-1376-8409","https://orcid.org/0000-0002-5222-4765"]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adrian L. Harris","raw_affiliation_strings":["Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071537151","display_name":"Anthony H. Kong","orcid":"https://orcid.org/0000-0002-3989-3948","observed_orcids":["https://orcid.org/0000-0002-3989-3948"]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anthony Kong","raw_affiliation_strings":["Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]},{"raw_affiliation_string":"Human Epidermal Growth Factor Group, Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.7861,"has_fulltext":true,"cited_by_count":88,"citation_normalized_percentile":{"value":0.97530012,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"5","issue":"16","first_page":"6633","last_page":"6646"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-resistance","display_name":"trastuzumab resistance","score":0.9929999709129333},{"id":"https://openalex.org/keywords/adam10","display_name":"ADAM10","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adam17","display_name":"ADAM17","score":0.9480000138282776},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.6299999952316284},{"id":"https://openalex.org/keywords/her2-phosphorylation","display_name":"HER2 phosphorylation","score":0.6190000176429749},{"id":"https://openalex.org/keywords/adam-proteases","display_name":"ADAM proteases","score":0.6119999885559082},{"id":"https://openalex.org/keywords/patient-survival","display_name":"patient survival","score":0.6790000200271606},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8090000152587891},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.3659999966621399}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9402105212211609},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7812225818634033},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7615667581558228},{"id":"https://openalex.org/C191560914","wikidata":"https://www.wikidata.org/wiki/Q7390592","display_name":"SKBR3","level":5,"score":0.6783758401870728},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5560413002967834},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5372735261917114},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5179756879806519},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4126792550086975},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39770424365997314},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000072197","descriptor_name":"ADAM10 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051722","descriptor_name":"ADAM Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051722","descriptor_name":"ADAM Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051722","descriptor_name":"ADAM Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053829","descriptor_name":"Amyloid Precursor Protein Secretases","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D053829","descriptor_name":"Amyloid Precursor Protein Secretases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053829","descriptor_name":"Amyloid Precursor Protein Secretases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055785","descriptor_name":"Gene Knockdown Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":8,"locations":[{"id":"doi:10.18632/oncotarget.1955","doi":"https://doi.org/10.18632/oncotarget.1955","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.1955","pdf_url":"https://www.oncotarget.com/article/1955/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4196152","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4196152","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmid:24952873","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24952873","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:openaire/3d01b6c4-9054-40e6-af50-c780a03bf0a0","doi":null,"is_oa":true,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/3d01b6c4-9054-40e6-af50-c780a03bf0a0","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Feldinger, K, Generali, D, Kramer-Marek, G, Gijsen, M, Ng, T B, Wong, J H, Strina, C, Cappelletti, M, Andreis, D, Li, J-L, Bridges, E, Turley, H, Leek, R, Roxanis, I, Capala, J, Murphy, G, Harris, A L & Kong, A 2014, 'ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer', Oncotarget, vol. 5, no. 16, pp. 6633-6646. https://doi.org/10.18632/oncotarget.1955","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pearl.plymouth.ac.uk:10026.1/5250","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10026.1/5250","pdf_url":"http://hdl.handle.net/10026.1/5250","source":{"id":"https://openalex.org/S4306402507","display_name":"PEARL (University of Plymouth)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I897542642","host_organization_name":"University of Plymouth","host_organization_lineage":["https://openalex.org/I897542642"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"journal-article"},{"id":"pmh:oai:pearl.plymouth.ac.uk:bhs-research-1329","doi":null,"is_oa":true,"landing_page_url":"https://pearl.plymouth.ac.uk/bhs-research/330","pdf_url":"https://pearl.plymouth.ac.uk/context/bhs-research/article/1329/viewcontent/ADAM10_20mediates_20trastuzumab_20resistance_20and_20is_20correlated_20with_20survival_20in_20HER2_20positive_20breast_20cancer.pdf","source":{"id":"https://openalex.org/S4306402507","display_name":"PEARL (University of Plymouth)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I897542642","host_organization_name":"University of Plymouth","host_organization_lineage":["https://openalex.org/I897542642"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"School of Biomedical Sciences","raw_type":"article"},{"id":"pmh:oai:arts.units.it:11368/2857745","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11368/2857745","pdf_url":null,"source":{"id":"https://openalex.org/S4306400480","display_name":"ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142444530","host_organization_name":"University of Trieste","host_organization_lineage":["https://openalex.org/I142444530"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/8cb73549-8de1-469e-91ae-73a4195b9951","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/8cb73549-8de1-469e-91ae-73a4195b9951","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Feldinger, K, Generali, D, Kramer-Marek, G, Gijsen, M, Ng, T B, Wong, J H, Strina, C, Cappelletti, M, Andreis, D, Li, J-L, Bridges, E, Turley, H, Leek, R, Roxanis, I, Capala, J, Murphy, G, Harris, A L & Kong, A 2014, 'ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer', OncoTarget, vol. 5, no. 16, pp. 6633-6646. https://doi.org/10.18632/oncotarget.1955","raw_type":"article"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.1955","doi":"https://doi.org/10.18632/oncotarget.1955","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.1955","pdf_url":"https://www.oncotarget.com/article/1955/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1425849753","display_name":null,"funder_award_id":"11359","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G7499079676","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0611-10163","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G8801512839","display_name":null,"funder_award_id":"16464","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1506037014.pdf","grobid_xml":"https://content.openalex.org/works/W1506037014.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W1597931794","https://openalex.org/W1742822977","https://openalex.org/W1939128981","https://openalex.org/W1965804235","https://openalex.org/W1972039621","https://openalex.org/W1977048606","https://openalex.org/W1987003603","https://openalex.org/W1993804787","https://openalex.org/W1997215642","https://openalex.org/W1997894998","https://openalex.org/W2006174096","https://openalex.org/W2018692167","https://openalex.org/W2019116727","https://openalex.org/W2024651005","https://openalex.org/W2028337591","https://openalex.org/W2040935952","https://openalex.org/W2047236596","https://openalex.org/W2051051838","https://openalex.org/W2059411043","https://openalex.org/W2068125497","https://openalex.org/W2072219853","https://openalex.org/W2073391234","https://openalex.org/W2075669011","https://openalex.org/W2080737967","https://openalex.org/W2090685720","https://openalex.org/W2096864872","https://openalex.org/W2099010186","https://openalex.org/W2100794900","https://openalex.org/W2103245406","https://openalex.org/W2111314225","https://openalex.org/W2114579860","https://openalex.org/W2115759102","https://openalex.org/W2116347075","https://openalex.org/W2131091972","https://openalex.org/W2133565210","https://openalex.org/W2135424430","https://openalex.org/W2140354367","https://openalex.org/W2141393790","https://openalex.org/W2144191082","https://openalex.org/W2146384083","https://openalex.org/W2148153122","https://openalex.org/W2149908785","https://openalex.org/W2152101209","https://openalex.org/W2156453405","https://openalex.org/W2157983986","https://openalex.org/W2159459001","https://openalex.org/W2172265576","https://openalex.org/W2318605753","https://openalex.org/W2388163742","https://openalex.org/W2589209282","https://openalex.org/W4239989216","https://openalex.org/W4244087642","https://openalex.org/W6982537396"],"related_works":["https://openalex.org/W2331574243","https://openalex.org/W3005261343","https://openalex.org/W1734411634","https://openalex.org/W2290578664","https://openalex.org/W2954799423","https://openalex.org/W2001485396","https://openalex.org/W2092165713","https://openalex.org/W4400832105","https://openalex.org/W2320647534","https://openalex.org/W2014982456"],"abstract_inverted_index":{"//":[0,216],"Katharina":[1],"Feldinger":[2],"1":[3,15,74,75],",":[4,8,12,16,21,26,30,34,38,42,46,50,54,58,62,66],"Daniele":[5,35],"Generali":[6],"3":[7,29,33,37,117],"Gabriela":[9],"Kramer-Marek":[10],"4,8":[11],"Merel":[13],"Gijsen":[14],"Tzi":[17],"Bun":[18],"Ng":[19],"5":[20,25,146],"Jack":[22],"Ho":[23],"Wong":[24],"Carla":[27],"Strina":[28],"Mariarosa":[31],"Cappelletti":[32],"Andreis":[36],"Ji-Liang":[39],"Li":[40,188],"2":[41,45,49,53,70,97],"Esther":[43],"Bridges":[44],"Helen":[47],"Turley":[48],"Russell":[51],"Leek":[52],"Ioannis":[55],"Roxanis":[56],"6":[57,167],"Jacek":[59],"Capala":[60],"4":[61,135],"Gillian":[63],"Murphy":[64],"7":[65,182],"Adrian":[67],"L.":[68],"Harris":[69],"and":[71,175,204,298,316,339,362,373,429,436],"Anthony":[72,213],"Kong":[73,166],"Human":[76],"Epidermal":[77],"Growth":[78,98],"Factor":[79,99],"Group,":[80,100],"Department":[81,101,168],"of":[82,86,90,102,106,110,138,148,152,157,169,198,202,291,411,422],"Oncology,":[83,103],"Weatherall":[84,104],"Institute":[85,105,197],"Molecular":[87,107],"Medicine,":[88,108,153],"University":[89,109,156,173],"Oxford,":[91,95,111,115,180],"John":[92,112],"Radcliffe":[93,113],"Hospital,":[94,114],"UK":[96,116,181,185,195,209],"U.O.":[118],"Multidisciplinare":[119],"di":[120,131],"Patologia":[121],"Mammaria,":[122],"U.S":[123],"Terapia":[124],"Molecolare":[125],"e":[126],"Farmacogenomica,":[127],"A.O.":[128],"Instituti":[129],"Ospitalieri":[130],"Cremona,":[132,133],"Italy":[134],"National":[136],"Institutes":[137],"Health,":[139],"Radiation":[140],"Oncology":[141],"Branch,":[142],"Bethesda":[143],"MD,":[144],"US":[145],"School":[147],"Biomedical":[149,177],"Sciences,":[150],"Faculty":[151],"The":[154],"Chinese":[155],"Hong":[158,165],"Kong,":[159,214],"Tai":[160],"Po":[161],"Road,":[162],"Sha":[163],"Tin,":[164],"Cellular":[170],"Pathology,":[171],"Oxford":[172,176],"Hospitals":[174],"Research":[178,184],"Centre,":[179,191],"Cancer":[183,199],"Cambridge":[186],"Institute,":[187],"Ka":[189],"Shing":[190],"Robinson":[192],"Way,":[193],"Cambridge,":[194],"8":[196],"Research,":[200],"Division":[201],"Radiotherapy":[203],"Imaging,":[205],"Belmont,":[206],"Sutton,":[207],"Surrey,":[208],"(New":[210],"address)":[211],"Correspondence:":[212],"email:":[215],"Keywords":[217],":":[218,225,230,235],"Trastuzumab,":[219],"resistance,":[220],"ADAM10,":[221],"HER2,":[222],"survival":[223,242,406],"Received":[224],"March":[226],"8,":[227,237],"2014":[228,233,238],"Accepted":[229],"May":[231,236],"7,":[232],"Published":[234],"Abstract":[239],"Trastuzumab":[240,322,368],"prolongs":[241],"in":[243,264,293,300,309,327,334,337,340,350,360,387,408,424],"HER2":[244,266,301,310,328,388,412,441],"positive":[245,302,311,329,389,413,442],"breast":[246,303,312,330,365,390,414,443],"cancer":[247,313,331,366,391,415,444],"patients.":[248,416,445],"However,":[249],"resistance":[250,299,426],"remains":[251],"a":[252,261,348,394,409,420,433,437],"challenge.":[253],"We":[254],"have":[255],"previously":[256],"shown":[257],"that":[258],"ADAM17":[259],"plays":[260],"key":[262],"role":[263,290,421],"maintaining":[265],"phosphorylation":[267],"during":[268],"trastuzumab":[269,296,358,363,395,428],"treatment.":[270],"Beside":[271],"ADAM17,":[272],"ADAM10":[273,292,305,325,353,371,376,400,423,431],"is":[274],"the":[275,289],"other":[276],"well":[277],"characterized":[278],"ADAM":[279],"protease":[280],"responsible":[281],"for":[282,440],"HER":[283],"ligand":[284],"shedding.":[285],"Therefore,":[286],"we":[287],"studied":[288],"relation":[294],"to":[295,344,427],"treatment":[297,323,396],"cancer.":[304],"expression":[306],"was":[307],"assessed":[308],"cell":[314],"lines":[315],"xenograft":[317],"mice":[318],"treated":[319],"with":[320,347,379,403],"trastuzumab.":[321],"increased":[324],"levels":[326,377,401],"cells":[332],"(p\u22640.001":[333],"BT474;":[335],"p\u22640.01":[336],"SKBR3)":[338],"vivo":[341],"(p\u22640.0001)":[342],"compared":[343],"control,":[345],"correlating":[346],"decrease":[349],"PKB":[351],"phosphorylation.":[352],"inhibition":[354],"or":[355],"knockdown":[356],"enhanced":[357],"response":[359,382],"na\u00efve":[361],"resistant":[364],"cells.":[367],"monotherapy":[369],"upregulated":[370],"(p\u22640.05);":[372],"higher":[374],"pre-treatment":[375],"correlated":[378,402],"decreased":[380],"clinical":[381],"(p\u22640.05)":[383],"at":[384],"day":[385],"21":[386],"patients":[392],"undergoing":[393],"window":[397],"study.":[398],"Higher":[399],"poorer":[404],"relapse-free":[405],"(p\u22640.01)":[407],"cohort":[410],"Our":[417],"studies":[418],"implicate":[419],"acquired":[425],"establish":[430],"as":[432],"therapeutic":[434],"target":[435],"potential":[438],"biomarker":[439]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}